U.S. Stock Movement | "Partnership Clarification" Triggers Volatility as Mangoceuticals (MGRX.US) Shares Swing Wildly

Stock News

Nov 14

On Friday, shares of telemedicine platform Mangoceuticals (MGRX.US) dropped nearly 13% in pre-market trading before recovering slightly to a 2.94% gain at market open, trading at $1.225. The company retracted its previous day's announcement, denying any partnership with Eli Lilly (LLY.US) and Novo Nordisk (NVO.US).

During Thursday's pre-market session, Mangoceuticals had claimed collaborations with Eli Lilly and Novo Nordisk, stating it would provide GLP-1 weight-loss drugs from these pharmaceutical giants through its MangoRx Direct and PeachesRx Direct programs. However, the situation took a sharp turn when Eli Lilly publicly refuted the partnership, and Novo Nordisk also failed to confirm the claims.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1142465697"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1142465697\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1142465697?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-14 23:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1142465697","market":"hk","top_or_hot":-1,"title":"U.S. Stock Movement | \"Partnership Clarification\" Triggers Volatility as Mangoceuticals (MGRX.US) Shares Swing Wildly","media":"Stock News","content":"<p>On Friday, shares of telemedicine platform Mangoceuticals (MGRX.US) dropped nearly 13% in pre-market trading before recovering slightly to a 2.94% gain at market open, trading at $1.225. The company retracted its previous day's announcement, denying any partnership with Eli Lilly (LLY.US) and Novo Nordisk (NVO.US).</p>\n<p>During Thursday's pre-market session, Mangoceuticals had claimed collaborations with Eli Lilly and Novo Nordisk, stating it would provide GLP-1 weight-loss drugs from these pharmaceutical giants through its MangoRx Direct and PeachesRx Direct programs. However, the situation took a sharp turn when Eli Lilly publicly refuted the partnership, and Novo Nordisk also failed to confirm the claims.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. Stock Movement | \"Partnership Clarification\" Triggers Volatility as Mangoceuticals (MGRX.US) Shares Swing Wildly</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. Stock Movement | \"Partnership Clarification\" Triggers Volatility as Mangoceuticals (MGRX.US) Shares Swing Wildly\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-11-14 23:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On Friday, shares of telemedicine platform Mangoceuticals (MGRX.US) dropped nearly 13% in pre-market trading before recovering slightly to a 2.94% gain at market open, trading at $1.225. The company retracted its previous day's announcement, denying any partnership with Eli Lilly (LLY.US) and Novo Nordisk (NVO.US).</p>\n<p>During Thursday's pre-market session, Mangoceuticals had claimed collaborations with Eli Lilly and Novo Nordisk, stating it would provide GLP-1 weight-loss drugs from these pharmaceutical giants through its MangoRx Direct and PeachesRx Direct programs. However, the situation took a sharp turn when Eli Lilly publicly refuted the partnership, and Novo Nordisk also failed to confirm the claims.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MGRX","symbol_name":"Mangoceuticals, Inc.","start_time":0,"source_url":"","article_id":"1142465697","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1142465697","pubTimestamp":1763135290,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"On Friday, shares of telemedicine platform Mangoceuticals (MGRX.US) dropped nearly 13% in pre-market trading before recovering slightly to a 2.94% gain at market open, trading at $1.225. The company...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MGRX":"Mangoceuticals, Inc.","BK4128":"药品零售"},"translate_title":"美股动向|“合作关系澄清”引发波动芒果医药(MGRX.US)股价大幅波动","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MGRX":1},"content_text":"On Friday, shares of telemedicine platform Mangoceuticals (MGRX.US) dropped nearly 13% in pre-market trading before recovering slightly to a 2.94% gain at market open, trading at $1.225. The company retracted its previous day's announcement, denying any partnership with Eli Lilly (LLY.US) and Novo Nordisk (NVO.US).\nDuring Thursday's pre-market session, Mangoceuticals had claimed collaborations with Eli Lilly and Novo Nordisk, stating it would provide GLP-1 weight-loss drugs from these pharmaceutical giants through its MangoRx Direct and PeachesRx Direct programs. However, the situation took a sharp turn when Eli Lilly publicly refuted the partnership, and Novo Nordisk also failed to confirm the claims.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}